Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.
Dimainvest is a holding company owned by Umberto Di Maio, the controlling shareholder of Shedir Pharma Group.
Shedir Pharma Group manufactures and distributes nutraceuticals, cosmetics and medical devices. The company is headquartered in Piano di Sorrento, Italy.
Oaklins Italy’s parent company, Banca Akros, acted as the appointed broker for the collection of shares in the voluntary public tender offer for 11.9% of Shedir Pharma Group’s shares by Dimainvest.
Talk to the deal team
Related deals
Medicija has acquired Saulės Šeimos Medicinos Centras
Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.
Learn moreQuimpharma has completed the divestiture of a product portfolio to Megalabs
Quimpharma has completed the divestiture of a product portfolio to Megalabs México.
Learn moreSRT Marine has completed a placing and subscription
SRT Marine Systems plc has announced an equity raise of at least US$22 million at US$1.10 per share representing a 5.75% discount, through a US$19.4 million accelerated bookbuild placing and a US$2 million subscription by Ocean Infinity, alongside a separate retail offer of up to US$1.3 million.
Learn more